Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Amr I. Al Abbas"'
Autor:
Charles C. Vining, Kristine Kuchta, Amr I. Al Abbas, Phillip J. Hsu, Pierce Paterakos, Darryl Schuitevoerder, Divya Sood, Kevin K. Roggin, Mark S. Talamonti, Melissa E. Hogg
Publikováno v:
Surgical Endoscopy. 36:5710-5723
Publikováno v:
Updates in Surgery. 73:881-891
Minimally invasive distal pancreatectomy has become increasingly used in practice. While laparoscopic approach is the most commonly used technique, robotic distal pancreatectomy (RDP) has emerged as a safe, feasible and effective approach for distal
Autor:
Melissa E. Hogg, Jeffrey D. Borrebach, Amer H. Zureikat, Johanna E. Bellon, Henry A. Pitt, Herbert J. Zeh, Amr I. Al Abbas
Publikováno v:
Journal of Gastrointestinal Surgery. 25:1503-1511
Pancreatoduodenectomy (PD) is often performed in frail patients and is associated with significant morbidity. The five-factor modified frailty index (mFI-5) has been utilized to predict adverse postoperative outcomes, but has not been tested in PD. W
Autor:
Jae Pil Jung, Alessandro Paniccia, Mazen S. Zenati, Herbert J. Zeh, Kenneth K.W. Lee, Nathan Bahary, Melissa E. Hogg, Ana Gleisner, Amr I. Al Abbas, David L. Bartlett, Amer H. Zureikat
Publikováno v:
Annals of Surgical Oncology. 27:2961-2971
Neoadjuvant therapy (NT) is a growing strategy in localized head pancreatic adenocarcinoma (PDC). However, a significant portion of NT patients do not reach resection due to disease progression or performance status decline. We sought to identify pre
Autor:
Mazen S. Zenati, Amer H. Zureikat, Melissa E. Hogg, Amr I. Al Abbas, Herbert J. Zeh, Jae Pil Jung, Caroline J. Reiser, Ahmad Hamad
Publikováno v:
Ann Surg Oncol
INTRODUCTION: Optimal cut-offs for CA19-9 response after neoadjuvant therapy (NT) for pancreatic adenocarcinoma (PDAC) are not well characterized. This study aims to analyze the relationship of serum CA19-9 with other markers of response and identify
Publikováno v:
Journal of Gastrointestinal Surgery. 24:2259-2268
Higher MELD scores correlate with adverse operative outcomes regardless of the presence of liver disease, but their impact on pancreatectomy outcomes remains undefined. We aimed to compare 30-day adverse postoperative outcomes of patients undergoing
Autor:
Herbert J. Zeh, Amer H. Zureikat, Jianpeng Cai, Mazen S. Zenati, Melissa E. Hogg, Amr I. Al Abbas, Rajesh Ramanathan
Publikováno v:
Journal of Gastrointestinal Surgery. 24:1111-1118
Clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreatoduodenectomy (PD) is a major complication that adversely affects recovery. The robotic approach may decrease the incidence of this complication. This propensity-matched ana
Autor:
Amr I. Al Abbas, Melissa E. Hogg
Publikováno v:
Annals of Surgical Oncology. 27:2015-2016
Autor:
Amer H. Zureikat, Amr I. Al Abbas, Melissa E. Hogg, Herbert J. Zeh, Jae Pil Jung, Ahmad Hamad, Caroline J. Rieser, Mazen S. Zenati
Publikováno v:
Annals of Surgical Oncology. 27:965-965
In the original article, Caroline J. Rieser’s last name is spelled wrong. It is correct as reflected here.